Skip to main content

American Society of Hematology Annual MeetingUNC Lineberger Comprehensive Cancer Center researchers and UNC colleagues will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology (ASH) Annual Meeting in New Orleans, Dec. 10-13.

ASH is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, including cancer. This year’s meeting is expected to attract more than 25,000 hematology professionals, including clinicians, researchers, medical students and patient advocates.

UNC Lineberger and UNC researchers presenting at the meeting include:

Friday, Dec. 9

1:30-2 p.m. CT  | 2:40-3:10 p.m. CT  |  4:35-5 p.m. CT  | River City Ballroom (Mardi Gras World)

Blood Buddies: Adult Clinical Classical Hematology

Presenter: Alice Ma, MD

 

Symposium

2:50-3:50 p.m. CT  | 295-296

Scientific Workshop on Interplay between Coagulation and Malignancy Program: Scientific Workshops

Moderator: Nigel Mackman, PhD

 

Saturday, Dec. 10

Career Development Lunch

11:15 a.m.-12:15 p.m. CT  |  St. Charles Ballroom (Hilton New Orleans Riverside)

Adult Clinical Classical Hematology

Presenter: Stephan Moll, MD

 

Oral Presentation

12-1:30 p.m. CT  |  243-245

 

12:45 p.m. CT

172 “…Paying to be a Patient in the Hospital and the Parking Lot”: Dyadic Perspectives on Multiple Myeloma-Related Healthcare Access Barriers

Gabriell Erisnor, BS, Jiona Mills, BSPH, Paul Mihas, MA, Lauren Bates, MA, Mykela Moore, BA, Tanya M. Wildes, MD, Leah Adams, BS, Hyman B Muss, MD, and Shakira J. Grant, MBBS

Presenter: Shakira J. Grant, MBBS

 

2-3:30 p.m. CT  |  391-392

 

3:15 p.m. CT

270 Associations of Minor Histocompatibility Antigens with Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation

Othmane Jadi, BA, BS, Hancong Tang, PhD, Kelly Shea Olsen, MSc, Steven Vensko, PhD, Qianqian Zhu, PhD5, Yiwen Wang, Christopher A. Haiman, Loreall Pooler, Xin Sheng, MS, Guy Brock, PhD, Amy Webb, PhD, Marcelo C Pasquini, MD, MS, Philip L. McCarthy, MD, Stephen R. Spellman, Theresa E. Hahn, PhD, Benjamin G. Vincent, MD, Paul M. Armistead, MD, PhD, and Lara E. Sucheston-Campbell, PhD, MS

Presenter: Othmane Jadi, BA, BS

 

4-5:30 p.m. CT  |  208-210

 

4:15 p.m.

 

380 “If You Don’t Trust Your Doctor That Much…You’d Feel Less Confident Doing a Research Study”: Factors Influencing Black Patient Participation in Hematology Trials

Shakira J. Grant, MBBS, Milenka Jean-Baptiste, MPH, Mykela Moore, BA, Jiona Mills, BSPH, Lauren Bates, MA, Sascha A. Tuchman, MD, MHS, and Paul Mihas, MA

Presenter: Shakira J. Grant, MBBS

 

5 p.m.

383 “You Have Your Knowledge, but I Have My Knowledge of My Body”: The Hematologist-Patient Relationship and Enrollment of Black Participants in Clinical Trials

Shakira J. Grant, MBBS, Milenka Jean-Baptiste, MPH, Mykela Moore, BA, Jiona Mills, BSPH, Lauren Bates, MA, Sascha A. Tuchman, MD, MHS, and Paul Mihas, MA

Presenter: Shakira J. Grant, MBBS

 

Poster Presentation

5:30-7:30 p.m. CT  |  Hall D

 

1046 Protease Activated Receptor-1 (PAR-1) Inhibition By Parmodulin 2, but Not Vorapaxar, Protects Sickle Cell Mice from Heme-Induced Acute Chest Syndrome

Kailyn Lowder, Nirupama Ramadas, PhD, Rafal Pawlinski, PhD, and Erica Sparkenbaugh, PhD

Presenter: Kailyn Lowder

 

1061 Balanced Crystalloids Versus Normal Saline in Noncritically Ill Adults with Sickle Cell Disease Admitted from the Emergency Department: A Sub-Analysis of the Salt-ED Trial

Marcus A. Carden, MD, Jeffrey D. Lebensburger, DO, Vimal K Derebail, MD, and Wesley H. Self, MD, MPH

Presenter: Marcus A. Carden, MD

 

1062 Evaluating Equations for Estimated Glomerular Filtration Rate (eGFR) in Patients with Sickle Cell Disease (SCD)

Vimal K Derebail, MD, MPH, Laura Y Zhou, MS, Laila Elsherif, PhD, Kammie L Patillo, RN, David Wichlan, Kristina Landes, MPH, Paula McCune, RN, Laura R Loehr, MD, PhD, MS, Robert M Cronin, MD, MS, Payal C Desai, MD, Jianwen Cai, PhD, and Kenneth I Ataga, MD

Presenter: Vimal K Derebail, MD, MPH

 

1458 Is Disease Response a Patient-Centered Clinical Trial Endpoint in Acute Myeloid Leukemia: Differences in Symptom Burden and Physical Function By Response Status in the Beat-AML Master Trial

Antonia V. Bennett, PhD, Xianming Tan, PhD, Matthew C. Foster, MD, Daniel R. Richardson, MD, MSc, MA, Ashley L. Bryant, PhD, RN, OCN, FAAN, William A. Wood, MD, MPH, Ashley O. Yocum, PhD, Alice S. Mims, MD, Uma Borate, MD, and Amy Burd, PhD

Presenter: Antonia V. Bennett, PhD

 

1943 Absence of ILC2 Recovery Post-Transplant Is Mediated By Epigenetic Conversion of ILC2 to Pro-Inflammatory ILC1-like Cells

Sonia J. Laurie, PhD, Joseph P. Foster II, BS, Danny W. Bruce, PhD, Hemamalini Bommiasamy, PhD, Samantha G. Pattenden, PhD, Ian J. Davis, MD, PhD, and Jonathan S. Serody, MD

Presenter: Sonia J. Laurie, PhD

 

1948 Shared Graft Versus Leukemia Minor Histocompatibility Antigens in DISCOVeRY-BMT

Kelly Shea Olsen, MSc, Othmane Jadi, BA, BS, Sarah Dexheimer, MSc, Dante Bortone, PhD, Steven Vensko, PhD, Hancong Tang, PhD, Marisa Diiorio, BA, Tanvi Saran, BS, David Dingfelder, Sarah Bennett, BS, Qianqian Zhu, PhD, Yiwen Wang, Christopher A. Haiman, Loreall Pooler, Xin Sheng, MS, Amy Webb, PhD, Marcelo C Pasquini, MD, MS, Philip L. McCarthy, MD, Stephen R. Spellman, Eric T. Weimer, PhD, Theresa E. Hahn, PhD, Lara E. Sucheston-Campbell, PhD, Paul M. Armistead, MD, PhD, and Benjamin G. Vincent, MD (Drs. Armistead and Vincent are co-last authors)

Presenter: Kelly Shea Olsen, MSc

 

1975 Characterization of a Cyclic Dinucleotide Metabolic Switch to Fuel Antitumor Immunity

Jeremy A. Meier, MD, PhD, Katie E. Hurst, MPH, David L. Corcoran, Jessica E. Thaxton, PhD, and Jonathan S. Serody, MD

Presenter: Jeremy A. Meier, MD, PhD

 

2287 Functional Status and Mortality Among Older Adults with Multiple Myeloma

Christopher E. Jensen, MD, Tzy-Mey Kuo, PhD, MPH, Matthew Leblanc, PhD, BSN, RN, Chris D Baggett, PhD, Xi Zhou, Katherine E Reeder-Hayes, and Jennifer L Lund, PhD

Presenter: Christopher E. Jensen, MD

 

Sunday, Dec. 11

 

How I Treat: Bringing Science to Clinical Dilemmas

8-9 a.m.  |  Marlborough A (Hilton New Orleans Riverside)

 

Thrombosis and Anticoagulation – Duration of Therapy, Thrombophilia

Presenter: Stephan Moll, MD

 

Plenary Scientific Session

2-4 p.m. CT  |  Hall E

 

5 C1 Inhibitor Deficiency Results in Increased Activation of Coagulation and Enhanced Venous Thrombosis

Steven P Grover, PhD, Tomohiro Kawano, MD, PhD, Linda Sundler Bjorkman, MD, Francesco P Giorgino, BSc, Sophia Dhrolia, Rohan Kasthuri, Sigrid Braekkan, PhD, Zsofia Polai, Henriette Farkas, MD, PhD, Arne Egesten, MD, PhD, John-Bjarne Hansen and Nigel Mackman, PhD

Presenter: Steven P. Grover, PhD

 

Symposium

4:30-6 p.m. CT  |  288-290

 

Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological Program: Oral and Poster Abstracts

 

Moderator: Alice Ma, MD

 

Poster Presentation

6-8 p.m. CT  |  Hall D

 

2364 Parmodulin, an Allosteric Inhibitor of Protease Activated Receptor 1 (PAR1) Protects Sickle Cell Mice from Thromboinflammation and Endothelial Dysfunction

Nirupama Ramadas, PhD, Kailyn Lowder, Laurent O. Mosnier, PhD, Rafal Pawlinski, PhD, and Erica Sparkenbaugh, PhD

Presenter: Nirupama Ramadas, PhD

 

2437 Decreased Platelet Reactivity and Function in a Mouse Model of Pancreatic Cancer

Tomohiro Kawano, MD, PhD, Yohei Hisada, PhD, Steven P Grover, PhD, Wyatt Schug, David Paul, Wolfgang Bergmeier, and Nigel Mackman, PhD

Presenter: Tomohiro Kawano, MD, PhD

 

2442 Accelerated Platelet Clearance in Mice with Constitutive Store-Operated Calcium Entry Is Independent of Caldag-GEFI/Rap1 Activation

Robert H Lee, PhD, Bernhard Nieswandt, PhD, and Wolfgang Bergmeier

Presenter: Robert H. Lee, PhD

 

2946 A Pilot Study Evaluating Acalabrutinib for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphomas

Christopher Dittus, DO, MPH, Roy Ervin Strowd III, MD, MEd, MS, Kelly Hoye, MS, CCRP, Xianming Tan, PhD, Jordan Miller, PharmD, Celeste Bello, MD, Amir Khandani, MD, and Anne W. Beaven, MD

Presenter: Christopher Dittus, DO, MPH

 

2933 ABVD for Hodgkin Lymphoma in Malawi; Excellent Outcomes but with Persistent Clinical Disparities Compared to High-Income Countries: A Prospective Cohort Study

Marriam Mponda, MBBS, Evaristar Kudowa, MPH, Bongani Kaimila, MBBS, Edwards Kasonkanji, MPH, Noel Mumba, Dip Clin Med, Lusayo Simwinga, MBBS, Tamiwe Tomoka, MBBS, Yuri Fedoriw, MD, and Matthew Painschab, MD

Presenter: Marriam Mponda, MBBS

 

3285 Development of a mRNA Lipid Nanoparticle (mRNA-LNP) Cancer Vaccine to Prevent Leukemia Relapse after Stem Cell Transplant

Anson Snow, MD, Lin Lin, PhD, Sally A. Hunsucker, PhD, Ying Wang, PhD, Rihe Liu, PhD, and Paul M. Armistead, MD, PhD

Presenter: Anson Snow, MD

 

3517 Establishment and Utilization of an Advanced Practice Provider-Led Clinic for Newly Diagnosed Venous Thromboembolism

Cassiopeia Frank, PA-C, Nigel S. Key, Micah J. Mooberry, MD, Raj S. Kasthuri, MD, and Stephan Moll, MD

Presenter: Cassiopeia Frank, PA-C

 

3552 Strategies for Implementing an Oral Medication Adherence Intervention in Academic and Community Cancer Settings

James B. Collins IV, PharmD, Michele A. Muir, PharmD, Emily Mackler, PharmD, Ashley L. Bryant, PhD, RN, OCN, FAAN, William A. Wood, MD, MPH, Stephanie Wheeler, PhD, MPH, Leah Zullig, PhD, MPH, Jennifer E. Lafata, PhD, and Benyam Muluneh, PharmD

Presenter: James B. Collins IV, PharmD

 

Monday, Dec. 12

 

Spotlight Session

2:45-4 p.m.  |   288-290

 

Point/Counterpoint: The case FOR thrombophilia testing in many/most adults with unprovoked thrombosis

Presenter: Stephan Moll, MD

 

Oral Presentation

3 p.m. CT  |  220-222

 

800 ETO2 Recruitment of NuRD to the γ-Globin Locus Involves Multivalent Interaction with GATAD2A

David C. Williams, MD, PhD, Gage Oliver Leighton, Parnika Agrawal, Glory Dan-Dukor, Shengzhe Shang, and Gordon Ginder, MD

Presenter: David C. Williams, MD, PhD

 

Special-Interest Sessions

4:30-6 p.m. CT  |  217-219

 

Driving Real-World Evidence for Hematologic Malignancy Research – A Joint ASH RC and EU HARMONY Session

Chair: William A. Wood, MD, MPH

Moderator: Samuel Rubinstein, MD

 

Poster Presentation

6-8 p.m. CT  |  Hall D

 

3701 The Prevalence and Impact of Low Oxygen in People with Sickle Cell Anemia: A Pilot Study

Ada Chang, BSc, Sherri Morris, MSN, AGPCNP-BS, Barbara L LeVarge, MD, Samuel R Wilson, MD, MSCR, and Jane Alison Little, MD

Presenter: Ada Chang, BSc

 

3754 Thrombocytopenia in a Mouse Model of Pancreatic Cancer

Michelle M. Luo, Yaqiu Sang, PhD, Maria N. Barrachina, PhD, Andrew P. Stone, PhD, Keely G. Davey, PhD, Yi Yang, PhD, Lori A. Holle, PhD, Tomohiro Kawano, MD, PhD, Nigel Mackman, PhD, Matthew J. Flick, PhD, Kellie R. Machlus, PhD, and Alisa S. Wolberg, PhD

Presenter: Michelle M. Luo

 

3755 Identification of Receptors and Signaling Pathways Mediating the Platelet Contribution to Clotting Parameters in Thromboelastography (TEG)

Robert H Lee, PhD, Tanvi Rudran, Silvio Antoniak, Alisa S. Wolberg, PhD, and Wolfgang Bergmeier

Presenter: Robert H. Lee, PhD

 

3778 Mathematical Modeling to Identify Clotting Factor Combinations That Modify Thrombin Generation in Hemophilia

Michael Stobb, Dougald Monroe, PhD, Keith B. Neeves, PhD, Suzanne Sindi, Aaron Fogelson, and Karin Leiderman, PhD

Presenter: Karin Leiderman, PhD

 

4085 A Phase 1b Dose Escalation and Expansion Study of SNDX-5613, Azacitidine (AZA) and Venetoclax (VEN) in Newly Diagnosed, Patients ≥ 60 Years with Untreated NPM1-Mutated/ FLT3-Wild Type AML or KMT2A-Rearranged Acute Myeloid Leukemia (AML)

Joshua F. Zeidner, MD, Matthew C. Foster, MD, Mary Johnson, Ying Huang, MS, MA, Ronan T. Swords, MD, Eytan Stein, MD, James M. Foran, MD, Maria R. Baer, MD, Wendy Stock, MD, Yazan F. Madanat, MD, Tibor Kovacsovics, MD, Rebecca L. Olin, MD, William G. Blum, MD, Gary J. Schiller, MD, Tara L. Lin, MD, Robert L. Redner, MD, Zeina Al-Mansour, MD, Emily K Curran, MD, Nyla A. Heerema, PhD, Molly Martycz, Leonard Rosenberg, PhD RPh, Sonja Marcus, MPH, Ashley O. Yocum, PhD, Timothy Chen, PhD, Mona Stefanos, Franchesca Druggan, MSc, Amy Burd, PhD, Ross L. Levine, MD, Brian J. Druker, Uma Borate, MD, John C. Byrd, MD, and Alice S. Mims, MD

Presenter: Joshua F. Zeidner, MD

 

4086 Changes in Symptoms, Function, and Quality of Life in Older Adults with Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents

Ya-Ning Chan, PhD, RN, Daniel R. Richardson, MD, MSc, MA, Courtney Berry, BS, MA, BSN, RN, OCN, Stephanie Betancur, BSN, RN, Hayden Michael Dumaw, BS, Todd Schwartz, DrPH, Mackenzi Pergolotti, PhD, OTR/L, Susan Coppola, MS, OT/L, OTD, FAOTA, Christopher Jensen, MD, Matthew C. Foster, MD, and Ashley L. Bryant, PhD, RN, OCN, FAAN

Presenter: Ashley L. Bryant, PhD, RN, OCN, FAAN

 

4582 Amphiregulin Derived from Multiple Sources Is Important for Barrier Function of the Intestine Following Hematopoietic Stem Cell Transplantation

Danny W. Bruce, PhD, Oleg Kolupaev, PhD, Sonia J. Laurie, PhD, Hemamalini Bommiasamy, PhD, and Jonathan S. Serody, MD

Presenter: Danny W. Bruce, PhD

 

4594 Cytotoxic Therapy Impairs the Stromal Niche Supporting ILC Development in the Bone Marrow

Oleg Kolupaev, PhD, Danny W. Bruce, PhD, Sonia J. Laurie, PhD, Hemamalini Bommiasamy, PhD, and Jonathan S. Serody, MD

Presenter: Oleg Kolupaev, PhD